Iquitos Virus in Traveler Returning to the United States from Ecuador
Katherine Baer
1, Itika Arora
1, Jayden Kimbro, Ali Haider, Michelle Mott, Kyleigh Marshall, Henry M. Wu, Jessica Fairley, Anne Piantadosi, David R. Myers, and Jesse J. Waggoner
Author affiliation: Emory TravelWell Center, Atlanta, Georgia, USA (K. Baer); Emory University School of Medicine, Atlanta (K. Baer, I. Arora, J. Kimbro, A. Haider, M. Mott, H.M. Wu, J. Fairley, A. Piantadosi, J.J. Waggoner); Emory University Rollins School of Public Health, Atlanta (K. Marshall, J. Fairley, J.J. Waggoner); Emory University, Atlanta (D.R. Myers); Georgia Institute of Technology, Atlanta (D.R. Myers); American and Asian Centers for Arboviral Research and Enhanced Surveillance, Atlanta (J.J. Waggoner)
Main Article
Figure 2
Figure 2. Maximum-likelihood phylogenetic analyses of the small segment (A), large segment (B), and medium segment (C) of Iquitos virus from a traveler returning to the United States from Ecuador. Sequences from the study have been deposited into GenBank (accession nos. PQ325301–4); reference sequences were obtained from National Center for Biotechnology Information Virus database. Panels A and B contain all available complete Oropouche small and large virus sequences, after removing identical sequences; panel C contains all available complete medium sequences for Iquitos, Oropouche, Itaya, Jatobal, Madre de Dios, and Perdoes viruses. Nodes with black circles have ultrafast bootstrap values >90. Sequence names are color-coded according to country of origin. Nucleotide substitution models were as follows: small segment, transversion model with empirical base frequencies and a gamma distribution of rates with 4 categories and α = 0.081; medium segment; transition model with empirical base frequencies and a gamma distribution of rates with 4 categories and α = 5.156; and large segment: general time-reversible model with empirical base frequencies, allowing for invariant sites and a gamma distribution of rates with 2 categories and α = 0.125. Scale bars indicate number of nucleotide substitutions per site.
Main Article
Page created: September 30, 2024
Page updated: October 23, 2024
Page reviewed: October 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.